Kamada (KMDA) Net Cash Flow (2012 - 2026)

Kamada (KMDA) posted quarterly Net Cash Flow of -$42.3 million for Q1 2026, down 1768.71% year-on-year from $2.5 million in Q1 2025, and down 1272.34% on a QoQ basis from $3.6 million in Q4 2025.

Kamada (KMDA) Net Cash Flow (2012 - 2026) Analysis & Trends

Kamada (KMDA) has reported Net Cash Flow for 15 consecutive years, with -$42.3 million the latest figure, recorded in Q1 2026.

  • Quarterly Net Cash Flow fell 1768.71% year-over-year to -$42.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$42.8 million (down 252.33% YoY) and the FY2025 annual result came in at -$2.7 million, down 111.74% from the prior year.
  • Net Cash Flow fell to -$42.3 million in Q1 2026 per KMDA's latest filing, from $3.6 million in the prior quarter.
  • Over the last five years, Net Cash Flow for KMDA reached as high as $30.5 million in Q3 2023 and fell as low as -$42.3 million in Q1 2026.
  • A 5-year average of $762796.0 and a median of $2.6 million in 2023 frame the typical range for Net Cash Flow.
  • Annual changes were most pronounced in 2023 — Net Cash Flow surged 1887639.94% — and 2024, when it plunged 108339.56%.
  • Year by year, Net Cash Flow stood at -$3.8 million in 2022, then soared by 166.54% to $2.6 million in 2023, then jumped by 164.71% to $6.8 million in 2024, then plunged by 46.62% to $3.6 million in 2025, then plunged by 1272.34% to -$42.3 million in 2026.
  • According to Business Quant data, Net Cash Flow over the past three periods registered -$42.3 million, $3.6 million, and $6.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 202.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -526.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 711.50 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -277.40 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 461.90 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -446.50 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -112.00 Mn
10 Kamada 401.22 Mn 328.07 Mn 19.12 Mn -42.35 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -42.35 Mn
Mar 31, 2026 -42.35 Mn
Dec 31, 2025 3.61 Mn
Dec 31, 2025 3.61 Mn
Sep 30, 2025 6.07 Mn
Sep 30, 2025 6.07 Mn
Jun 30, 2025 -10.11 Mn
Jun 30, 2025 -10.11 Mn
Mar 31, 2025 -2.27 Mn
Mar 31, 2025 -2.27 Mn
Dec 31, 2024 6.77 Mn
Dec 31, 2024 6.77 Mn
Sep 30, 2024 15.30 Mn
Sep 30, 2024 15.30 Mn
Jun 30, 2024 8.28 Mn
Jun 30, 2024 8.28 Mn
Mar 31, 2024 -7.40 Mn
Mar 31, 2024 -7.40 Mn
Dec 31, 2023 2.56 Mn
Dec 31, 2023 2.56 Mn